PillRx only · Kit
Risperidone
Brands: Risperdal Consta · Rykindo Extended-Release Microspheres
4 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US14 NDCs
4 active makers
4 active makers
UKComing
soon
soon
CAComing
soon
soon
AUComing
soon
soon
EUComing
soon
soon
US acquisition costNADAC · per unit
Average across 10 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.
$655.299
Latest avg · Jul 22, 2026
-10%
Since Aug 20, 2025
4
Active US suppliers
67%
Top-2 supplier share*
Medicaid dispensing volumeSDUD · per quarter
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.
19K
Rx · 2026 Q1
26K
Units dispensed
-25%
Rx vs. year ago
5
Quarters · since 2025 Q1
Who makes it4 active · 0 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Teva Pharmaceuticals USA, Inc. | unknown | 4 | SUPPLYING |
| Janssen Pharmaceuticals, Inc. | unknown | 4 | SUPPLYING |
| Lupin Pharmaceuticals,Inc. | unknown | 3 | SUPPLYING |
| Shandong Luye Pharmaceutical Co., Ltd. | unknown | 1 | SUPPLYING |
Regulatory & supply eventsFDA · US
Shortages, recalls, and registration changes attached to this drug concept.
- Sep 11, 2013RECALLRecall (Class II): Risperdal CONSTA (risperiDONE), 25 mg Dose Pack, Rx Only, Single Use Only Janssen Pharmaceuticals Inc., Titusville, N…
Non-Sterility: Janssen is recalling one lot of Risperdal CONSTA (risperiDONE) due to a sterility failure in a stability sample — Recalling firm: Janssen Pharmaceuticals, Inc. — Nationwide